Concepts (64)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pharyngeal Diseases | 1 | 2018 | 11 | 0.560 |
Why?
|
| Airway Obstruction | 1 | 2018 | 38 | 0.560 |
Why?
|
| Sleep Deprivation | 1 | 2018 | 16 | 0.550 |
Why?
|
| Hematoma | 1 | 2018 | 85 | 0.530 |
Why?
|
| Thrombocytopenia | 1 | 2018 | 59 | 0.530 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2018 | 94 | 0.510 |
Why?
|
| Public Health | 1 | 2018 | 188 | 0.480 |
Why?
|
| Fibroblast Growth Factors | 2 | 2014 | 77 | 0.190 |
Why?
|
| Pharynx | 1 | 2018 | 25 | 0.140 |
Why?
|
| Sex Distribution | 1 | 2018 | 252 | 0.130 |
Why?
|
| Age Distribution | 1 | 2018 | 262 | 0.130 |
Why?
|
| Health Surveys | 1 | 2018 | 319 | 0.130 |
Why?
|
| Lipotropic Agents | 1 | 2014 | 1 | 0.100 |
Why?
|
| Adipose Tissue, Brown | 2 | 2014 | 127 | 0.100 |
Why?
|
| Triiodothyronine | 1 | 2014 | 30 | 0.100 |
Why?
|
| Hypothyroidism | 1 | 2014 | 42 | 0.100 |
Why?
|
| Thyroxine | 1 | 2014 | 53 | 0.100 |
Why?
|
| Spatial Behavior | 1 | 2013 | 9 | 0.100 |
Why?
|
| Maze Learning | 1 | 2013 | 53 | 0.100 |
Why?
|
| Testosterone | 1 | 2013 | 128 | 0.090 |
Why?
|
| Lipid Metabolism | 1 | 2014 | 227 | 0.090 |
Why?
|
| Adipose Tissue, White | 1 | 2012 | 93 | 0.080 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 2739 | 0.080 |
Why?
|
| Adaptation, Physiological | 1 | 2012 | 132 | 0.080 |
Why?
|
| Thermogenesis | 1 | 2012 | 128 | 0.080 |
Why?
|
| Time Factors | 1 | 2018 | 3779 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 1663 | 0.080 |
Why?
|
| Male | 5 | 2018 | 31410 | 0.080 |
Why?
|
| Motor Activity | 1 | 2013 | 347 | 0.080 |
Why?
|
| Trans-Activators | 1 | 2012 | 321 | 0.080 |
Why?
|
| Gene Expression Regulation | 2 | 2014 | 1635 | 0.080 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 5682 | 0.070 |
Why?
|
| Risk Factors | 1 | 2018 | 5475 | 0.070 |
Why?
|
| Young Adult | 1 | 2018 | 4883 | 0.070 |
Why?
|
| Adolescent | 1 | 2018 | 6368 | 0.060 |
Why?
|
| United States | 1 | 2018 | 8189 | 0.050 |
Why?
|
| Aged | 1 | 2018 | 15147 | 0.040 |
Why?
|
| Humans | 2 | 2018 | 65845 | 0.040 |
Why?
|
| Adult | 1 | 2018 | 17579 | 0.040 |
Why?
|
| Middle Aged | 1 | 2018 | 18501 | 0.040 |
Why?
|
| Female | 2 | 2018 | 34425 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2014 | 3506 | 0.030 |
Why?
|
| Hyperthyroidism | 1 | 2014 | 19 | 0.030 |
Why?
|
| Hyperlipidemias | 1 | 2014 | 35 | 0.030 |
Why?
|
| Hormone Replacement Therapy | 1 | 2014 | 30 | 0.030 |
Why?
|
| Orchiectomy | 1 | 2013 | 40 | 0.020 |
Why?
|
| Corpus Striatum | 1 | 2013 | 99 | 0.020 |
Why?
|
| Choice Behavior | 1 | 2013 | 86 | 0.020 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2012 | 36 | 0.020 |
Why?
|
| Cold Temperature | 1 | 2012 | 53 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2014 | 710 | 0.020 |
Why?
|
| Hippocampus | 1 | 2013 | 277 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 859 | 0.020 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2012 | 103 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2014 | 400 | 0.020 |
Why?
|
| Animals | 3 | 2014 | 21493 | 0.020 |
Why?
|
| Rats | 1 | 2013 | 2005 | 0.020 |
Why?
|
| Liver | 1 | 2014 | 875 | 0.020 |
Why?
|
| Mice | 2 | 2014 | 11185 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2014 | 2168 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2014 | 789 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2012 | 2194 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2012 | 1391 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2012 | 1561 | 0.010 |
Why?
|